The NICE has refused to support the use of cholinesterase in mild AD. Drug companies are considering an unprecedented court appeal. There have been widespread protests in the UK
Furore over who gets Alzheimer's drug in the UK
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment